Chronic Kidney Disease Clinical Trial
Official title:
Using Contact Free Sensor to Analyse Cardio-respiratory Patterns in Order to Early Detect the Clinical Complications in the Hemodialysis Patients.
The incidence and prevalence of dialysis in Taiwan remains higher as compared to past
several years. The number of dialysis reported about 6-7 million people each year and the
2014 full-year cost estimation was about 330 million NTDs. According to age-standardized
population statistics in 1995, the number of dialysis per million population in 2006 year
were 372.2 people, 381.9 people in 2012 year and the annual growth rate of 0.43 percent
recorded.
EarlySense system is certified by TFDA, FDA and many other countries, which consists of
mainly two parts. One for the sensing element, which placed under the mattress and the other
one is AC-powered display panel bed. This system has the ability to monitor the patients
physiological functions just be in contact via bed. When the patient laid on bed, the sensor
which is placed under the bed would detects heart rate, breathing rate and activity level as
well as other physiological signals. The system is also able to distinguish between patients
in bed and out of bed during the operation to save the patient's records and information
(including heart rate, respiratory rate and level of activity, and may render trends). The
system is also have capability for real-time data transmission information which includes a
warning to the nurses' station or other monitoring center of the screen by providing
real-time information to nurse.
In this research project, we will use EarlySense equipment for continuous monitoring the
dialysis patient's physiological data along with clinical data such as A. acute
complications such as rapid changes in blood pressure, respiratory rate, movements of
patients and Nausea or vomiting, etc phenomenon's) B. Lab examination data C. Status of
patient whether patients hospitalized or not and patient death occurred or not. The study is
expected to have a pilot study for more than three months' duration. Through this EarlySense
continuous monitoring and gather the data, we will analyse to develop a prediction model and
confirmed with indicators. Evidences from these analytics would help to propose ways to
improve it and implement Positive predictive validity models.
Status | Active, not recruiting |
Enrollment | 140 |
Est. completion date | December 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - above 20 years old and under hemodialysis Exclusion Criteria: - patient with coronary artery disease or under treatment for coronary artery disease and patient with fever, any kind of infection, or taking antibiotics |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University | Tatung medical & healthcare technologies |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiac arrest | 6 months after enrollment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |